Correlation Analysis Between Disease Activity and Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Inflammatory Bowel Disease

References

• Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39–49. doi:10.1038/nrgastro.2017.136
   PubMed Web of Science ®Google Scholar
• Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30. doi:10.1016/S2468-1253(19)30333-4
   PubMed Web of Science ®Google Scholar
• Drossman DA. Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol. 1996;22(4):252–254.
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus A, Pittet V, Rossel J-B, von Känel R. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2016;14(6). doi:10.1016/j.cgh.2015.12.045
   Web of Science ®Google Scholar
• Alexakis C, Kumar S, Saxena S, Pollok R. Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(3):225–235. doi:10.1111/apt.14171
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus A, Andrews JM. It is high time to examine the psyche while treating IBD. Nat Rev Gastroenterol Hepatol. 2018;15(6):329–330. doi:10.1038/s41575-018-0004-y
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(3):752–762. doi:10.1097/MIB.0000000000000620
   PubMed Web of Science ®Google Scholar
• Sepehri S, Kotlowski R, Bernstein CN, Krause DO. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(6):675–683.
   PubMed Web of Science ®Google Scholar
• Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. doi:10.3389/fncel.2015.00392
   PubMed Web of Science ®Google Scholar
• D’Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132(2):763–786.
   PubMed Web of Science ®Google Scholar
• Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn’s disease activity index. national cooperative Crohn’s disease study. Gastroenterology. 1976;70(3):439–444.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the Gad-7. Arch Intern Med. 2006;166(10):1092–1097.
   PubMed Web of Science ®Google Scholar
• Litster B, Bernstein CN, Graff LA, et al. Validation of the Phq-9 for suicidal ideation in persons with inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(8):1641–1648. doi:10.1093/ibd/izy032
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen H, Zhang N, et al. Anxiety and depression symptoms of medical staff under Covid-19 epidemic in China. J Affect Disord. 2021;278:144–148. doi:10.1016/j.jad.2020.09.004
   PubMed Web of Science ®Google Scholar
• Liao J, Kang J, Li F, et al. A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus. BMC Psychiatry. 2022;22(1):591. doi:10.1186/s12888-022-04236-z
   PubMed Web of Science ®Google Scholar
• Gong Y, Zhou H, Zhang Y, et al. Validation of the 7-item generalized anxiety disorder scale (Gad-7) as a screening tool for anxiety among pregnant Chinese women. J Affect Disord. 2021:282. doi:10.1016/j.jad.2020.12.129
   Web of Science ®Google Scholar
• Tong X, An D, McGonigal A, Park S-P, Zhou D. Validation of the Generalized Anxiety Disorder-7 (Gad-7) among Chinese people with epilepsy. Epilepsy Res. 2016;120:31–36. doi:10.1016/j.eplepsyres.2015.11.019
   PubMed Web of Science ®Google Scholar
• Chen X-L, Zhong L-H, Wen Y, et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes. 2017;15(1):177. doi:10.1186/s12955-017-0753-2
   PubMed Web of Science ®Google Scholar
• Tarar ZI, Zafar MU, Farooq U, et al. Burden of depression and anxiety among patients with inflammatory bowel disease: results of a nationwide analysis. Int J Colorectal Dis. 2022;37(2):313–321. doi:10.1007/s00384-021-04056-9
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Hitchon CA, Walld R, et al. Increased burden of psychiatric disorders in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(2):360–368. doi:10.1093/ibd/izy235
   PubMed Web of Science ®Google Scholar
• Williet N, Sarter H, Gower-Rousseau C, et al. Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients. J Crohns Colitis. 2017;11(2):165–174. doi:10.1093/ecco-jcc/jjw145
   PubMed Web of Science ®Google Scholar
• Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103(8):1989–1997. doi:10.1111/j.1572-0241.2008.01980.x
   PubMed Web of Science ®Google Scholar
• Geiss T, Schaefert RM, Berens S, Hoffmann P, Gauss A. Risk of depression in patients with inflammatory bowel disease. J Dig Dis. 2018;19(8):456–467. doi:10.1111/1751-2980.12644
   PubMed Web of Science ®Google Scholar
• Sexton KA, Walker JR, Graff LA, et al. Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(3):473–483. doi:10.1097/MIB.0000000000001040
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006;131(2):410–419.
   PubMed Web of Science ®Google Scholar
• Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN. The relationship between symptoms of depression and anxiety and disease activity in IBD over time. Inflamm Bowel Dis. 2021;27(8):1285–1293. doi:10.1093/ibd/izaa349
   PubMed Web of Science ®Google Scholar
• Tabatabaeian M, Afshar H, Roohafza HR, et al. Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life. J Res Med Sci. 2015;20(6):577–584. doi:10.4103/1735-1995.165962
   PubMed Web of Science ®Google Scholar
• Lewis K, Marrie RA, Bernstein CN, et al. The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(10):1674–1680. doi:10.1093/ibd/izz045
   PubMed Web of Science ®Google Scholar
• Ghia J-E, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Reactivation of Inflammatory bowel disease in a mouse model of depression. Gastroenterology. 2009;136(7). doi:10.1053/j.gastro.2009.02.069
   PubMed Web of Science ®Google Scholar
• Ghia J-E, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008;118(6):2209–2218. doi:10.1172/JCI32849
   PubMed Web of Science ®Google Scholar
• Horst S, Chao A, Rosen M, et al. Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease. Dig Dis Sci. 2015;60(2):465–470. doi:10.1007/s10620-014-3375-0
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease. Gastroenterology. 2018;154(6). doi:10.1053/j.gastro.2018.01.027
   PubMedGoogle Scholar
• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481–1491.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4(8):632–642. doi:10.1016/s2468-1253(19)30089-5
   PubMed Web of Science ®Google Scholar
• Luo X-P, Mao R, Chen B-L, et al. Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease. Patient Prefer Adherence. 2017;11:23–31. doi:10.2147/PPA.S118589
   PubMed Web of Science ®Google Scholar
• Gao X, Tang Y, Lei N, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021;11(1):1440. doi:10.1038/s41598-021-81213-8
   PubMed Web of Science ®Google Scholar
• Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006;4(12):1491–1501.
   PubMed Web of Science ®Google Scholar
• Larsson K, Lööf L, Rönnblom A, Nordin K. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008;64(2):139–148. doi:10.1016/j.jpsychores.2007.10.007
   PubMed Web of Science ®Google Scholar
• Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80. doi:10.1016/j.jpsychores.2016.06.001
   PubMed Web of Science ®Google Scholar
• Nigro G, Angelini G, Grosso SB, Caula G, Sategna-Guidetti C. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol. 2001;32(1):66–68.
   PubMed Web of Science ®Google Scholar
• Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):1.
   PubMedGoogle Scholar
• Mardini HE, Kip KE, Wilson JW. Crohn’s disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 2004;49(3):492–497.
   PubMed Web of Science ®Google Scholar
• Iglesias M, Barreiro de Acosta M, Vázquez I, et al. Psychological impact of Crohn’s disease on patients in remission: anxiety and depression risks. Rev Esp Enferm Dig. 2009;101(4):249–257.
   PubMed Web of Science ®Google Scholar
• Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359–370. doi:10.1016/S2468-1253(21)00014-5
   PubMed Web of Science ®Google Scholar
• Jonefjäll B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M. Characterization of Ibs-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil. 2013;25(9). doi:10.1111/nmo.12163
   PubMed Web of Science ®Google Scholar
• Henriksen M, Høivik ML, Jelsness-Jørgensen L-P, Moum B. Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as in inflammation: results from a population-based study [the Ibsen study]. J Crohns Colitis. 2018;12(4):389–393. doi:10.1093/ecco-jcc/jjx152
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Williams CJM, Sood R, et al. Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2017;15(3). doi:10.1016/j.cgh.2016.05.012
   Web of Science ®Google Scholar
• Blackwell J, Saxena S, Petersen I, et al. Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study. Gut. 2021;70(9):1642–1648. doi:10.1136/gutjnl-2020-322308
   PubMed Web of Science ®Google Scholar
• Kochar B, Barnes EL, Long MD, et al. Depression is associated with more aggressive inflammatory bowel disease. Am J Gastroenterol. 2018;113(1):80–85. doi:10.1038/ajg.2017.423
   PubMed Web of Science ®Google Scholar
• Eissa N, Mujawar Q, Alabdoulsalam T, Zohni S, El-Matary W. The immune-sleep crosstalk in inflammatory bowel disease. Sleep Med. 2020;73:38–46. doi:10.1016/j.sleep.2020.04.020
   PubMed Web of Science ®Google Scholar
• Hao G, Zhu B, Li Y, Wang P, Li L, Hou L. Sleep quality and disease activity in patients with inflammatory bowel disease: a systematic review and meta-analysis. Sleep Med. 2020;75:301–308. doi:10.1016/j.sleep.2020.08.032
   PubMed Web of Science ®Google Scholar
• Ali T, Madhoun MF, Orr WC, Rubin DT. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19(11):2440–2443. doi:10.1097/MIB.0b013e3182a0ea54
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11(8):965–971. doi:10.1016/j.cgh.2013.01.021
   PubMed Web of Science ®Google Scholar
• Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part Ii. Inflamm Bowel Dis. 2018;24(5):966–976. doi:10.1093/ibd/izy015
   PubMed Web of Science ®Google Scholar
• Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I. Inflamm Bowel Dis. 2018;24(4):742–751. doi:10.1093/ibd/izx100
   PubMed Web of Science ®Google Scholar